Skip to content

By further segmenting study results, Stanford Medicine’s Irogue Igbinosa and collaborators have begun to tease out important health differences between different subsets of the population.

By further segmenting study results, Stanford Medicine’s Irogue Igbinosa and collaborators have begun to tease out important health differences between different subsets of the population.

Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.

Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.

Published on